Interview with Jitirto Kusnadi, President, Mersifarma
The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the majority of the market share. In this respect…
Address: Wisma Tiara 4th Floor Jl. Raya Pasar Minggu Km. 18 No. 17 Jakarta Indonesia
Tel: +62 21 7987683
Web: http://www.mersifarma.com/
PT Mersifarma TM, better known as “Mersi’, was established in 1997. The company initially focused on the manufacturing of medicines to combat Neuro-Psychiatric, Psychosomatic and Mental Health Diseases. Today other important areas of healthcare in which Mersi is involved are Internal Medicine, Pulmonary Diseases, Obstetrics-Gynaecology, Neuro-surgery, Ear-Nose and Throat Diseases, Dentistry, and advanced antibiotic therapeutic agents.
The Indonesian pharmaceutical market has gone through a series of developing phases which have ultimately led the domestic industry to gain the majority of the market share. In this respect…
How has the increasing international integration of the Indonesian economy influenced the challenges and transformations the BPOM went through in the past 9 years since its reorganization? The constant changes…
Millennium Pharmacon International has a long history, starting at its founding in 1952. Could you give our readers an overview of the company’s milestones, particularly those from the past decade?…
While the level of sales for pharmaceutical products is plunging in the US and Europe one of the core pillar of Solvay’s strategy is to have a stronger focus on…
The development of the Local Pharmaceutical industry companies has gone through rough times, competing from the very beginning with MNCs and going through the economic shock in the 90’s. In…
Local firms have assumed an increasing role in the Indonesian pharmaceutical market representing today more than 75% of the market share and being able to provide over 90% of the…
How challenging is it being for you to adapt to the Indonesian business mindset. My adaptation to Indonesia has been relatively smooth thanks to my past experience in different Asian…
For the last six years Soho Group has been the fastest growing pharmaceutical company in Indonesia, able to position itself among the top players in the industry. What have been…
The Indonesian Pharmaceutical industry has always held tremendous potential. Yet, somehow, over the past decades, the local industry was quickly dwarfed by regional powerhouses India and China, and even surpassed…
Since the installation of Mr. Fred Hassan in 2003, Schering-Plough has been oriented toward changes. At two years from your arrival you have been able to achieve IDR 170 billion…
See our Cookie Privacy Policy Here
